Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Functional
gastrin
-containing tumor cells were maintained for up to 8 wk without fibroblastoid cell overgrowth. Short-term cultures consisted mainly of colonies composed of small polygonal cells, 70%-90% of which stained positive for immunoreactive
gastrin
. Cultures exhibited limited growth but viability remained high for 2-3 wk. Culture medium contained component I, and
gastrin
34, 17, and 14. With time the major C-terminal
gastrin
species in medium changed from
gastrin
17 at 3 days to
gastrin
34 at 5 wk. Extracts of cultured cells contained
gastrin
34, 17, and 14;
gastrin
17 was the major form detected at all times. Ultrastructurally, cultured tumor cells retained morphological integrity for several weeks; however, with time changes in the appearance of the secretory granules accompanied by evidence of cellular retrodifferentiation were gradually observed. Secretin, gastrin-releasing peptide, 8-bromoadenosine 3':5'-cyclic monophosphate, and phorbol, 12-myristate, 13-acetate stimulated the release of
gastrin
from cultured cells in a time-dependent fashion. Secretin, bombesin, gastrin-releasing peptide, L-
tryptophan
, and ethylamine stimulated
gastrin
release in a dose-dependent fashion. Somatostatin 14 inhibited secretin, bombesin, and gastrin-releasing peptide stimulated
gastrin
release but did not alter basal release. Cultured cells demonstrated de novo
gastrin
synthesis, evidenced by their ability to incorporate radiolabeled amino acids into immunoadsorbable gastrinlike material. Primary cultures of
gastrin
-containing tumor cells free from stromal contamination offer unique advantages for studies of factors that regulate the synthesis and secretion of
gastrin
and may prove of potential value for studies on cell differentiation and growth.
...
PMID:Gastrinoma in vitro: morphological and physiological studies of primary cell cultures. 217 34
We have previously demonstrated that the peptide Boc-
L-Trp
-L-Leu-beta-Ala is a potent and specific antagonist of pentagastrin-stimulated acid secretion in both the rat and the dog. Using conventional solution phase methodology, the analogue biotinyl-
L-Trp
-L-Leu-beta-Ala was prepared in reasonable yield and purity and applied to cryostat sections of rat intestinal and other tissues. The sections were exposed to 5-10 micrograms of peptide and the bound analogue was visualised using streptavidin-fluorescein. The binding of the analogue was demonstrated in sections from fundus, duodenum, ileum, colon, and lung. However, the analogue failed to bind to tissue from the pancreas, heart, kidney, or liver. The binding of the probe was greatly reduced or completely inhibited by preincubation with Boc-
L-Trp
-L-Leu-beta-Ala, pentagastrin, or
gastrin
1-17. The distribution of the cells recognised by the probe was consistent with the distribution of histamine-containing enterochromaffin-like cells. The results of this study may have some bearing on current theories of the mechanism of
gastrin
-stimulated acid release.
...
PMID:Visualisation of the gastrin receptor within rat mucosa using a biotinylated gastrin antagonist. 234 52
An approach to the solid-phase segment condensation synthesis of the 17-peptide amide human
gastrin
-I has been developed. N alpha-amino and side-chain protection were provided by 9-fluorenylmethyloxycarbonyl (Fmoc) and tert.-butyl groups, and a series of anchors cleavable under mild conditions were used. The N-terminal pentapeptide pGlu-Gly-Pro-Trp-Leu-OH was prepared using a p-alkoxybenzyl ester linkage made by a preformed handle strategy. Cleavage, in 65% yield, was with the new Reagent M: CF3COOH-CH2Cl2-beta-mercaptoethanol--anisole (70:30:2:1), which was optimized to preserve the labile
tryptophan
residue. A new preformed handle procedure expedited solid-phase synthesis of the protected "middle" hexapeptide, Fmoc-(Glu(OtBu]5-Ala-OH, anchored as an o-nitrobenzyl ester. Chains were not lost during this assembly, and final photolytic cleavage (350 nm) in toluene--CF3CH2OH (4:1) occurred in 59% yield. Both protected intermediates were purified by simple gel filtration, whereupon they were shown to be pure by analytical HPLC, and gave satisfactory NMR and FABMS spectra. Last, the C-terminal hexapeptide, Tyr(tBu)-Gly-Trp-Met-Asp(OtBu)-Phe, was assembled on a tris(alkoxy)benzylamide "PAL" support. For the polymer-supported segment condensation, the middle and N-terminal pieces were added respectively in greater than 98% and 89% yields (judged by amino acid analysis and solid-phase sequencing), by overnight couplings in N,N-dimethylformamide (DMF) mediated by benzotriazolyl N-oxytrisdimethylaminophosphonium hexafluorophosphate (BOP) in the presence of 1-hydroxybenzotriazole (HOBt) and N-methylmorpholine (NMM). Racemization was 4% and 11% respectively at Ala and Leu. Cleavage with Reagent M followed by reversed-phase chromatography gave pure
gastrin
-I in an overall 30% isolated yield. These results compare favorably with those from a stepwise assembly.
...
PMID:Orthogonal solid-phase synthesis of human gastrin-I under mild conditions. 240 94
Using the "Bi-Digital O-Ring Test Imaging Technique", the author has been able to accurately localize meridians and acupuncture points that correspond to specific internal organs and has found that most general patterns of meridians and the number of acupuncture points on each of the meridians of specific internal organs of the 12 main internal organs described in the literature of ancient Chinese medicine, are more or less correct, with the exception of some variations and inaccuracies. Each meridian of specific internal organs was found to be connected to the organ representation area in the cerebral cortex of specific internal organs. The acupuncture point has an area and occupies 3-dimensional space. It has a circular or slightly oval boundary with diameter in the range of 3 mm to 2.7 cm, although 6-12 mm are the most common diameters in human adults, with the exception of the area outside the corners of the nailbeds of the fingers and toes. Using the "Bi-Digital O-Ring Test Molecular Identification Method", the author also found that within the boundary of most acupuncture points and meridian lines (including Heart, Stomach, and Triple Burner) were high concentrations of neurotransmitters and hormones, including Acetylcholine, Methionine-Enkephalin, Beta-Endorphin, ACTH, Secretin, Cholecystokinin, Norepinephrine, Serotonin, and GABA. On all these meridian lines, in addition to the above neurotransmitters and hormones, Dopamine, Dynorphin 1-13, Prostaglandin E1 (PGE1) and VIP were found, but the latter do not usually exist within the boundary of the acupuncture point with the exception of the center midline of the acupuncture point where the meridian line is situated. Serotonin, Norepinephrine, and Cholecystokinin appeared in either one of the above 2 patterns, depending on the individual. Usually, no significant amounts of these neurotransmitters and hormones were found at the surrounding area outside of meridian and acupuncture points. However, the essential amino acid
L-Tryptophan
(which is a precursor of Serotonin), was usually found outside of the boundary of the acupuncture point and the meridian but not within the boundary of the acupuncture point and the meridian. Wherever Serotonin appeared,
L-Tryptophan
disappeared significantly and when the Serotonin disappeared,
L-Tryptophan
reappeared. In addition to the above common neurotransmitters and hormones, the Heart meridian had additional Atrial Natriuretic Peptide in both the meridian and its acupuncture points. Similarly, the Stomach meridian had additional
Gastrin
in both the meridian and its acupuncture points. Likewise,the Triple Burner meridian had additional Testosterone (in the male) and Estrogen (especially Estriol and Estradiol in the female.
...
PMID:Connections found between each meridian (heart, stomach, triple burner, etc.) & organ representation area of corresponding internal organs in each side of the cerebral cortex; release of common neurotransmitters and hormones unique to each meridian and corresponding acupuncture point & internal organ after acupuncture, electrical stimulation, mechanical stimulation (including shiatsu), soft laser stimulation or QI Gong. 257 47
Benzotript (N-p-chlorobenzoyl-L-
tryptophan
) has been shown to be a receptor-antagonist in vivo and in vitro for peptides from the
gastrin
family. In the present study, we examine
tryptophan
, and some of its N- and C-acylated derivatives, as well as some phenylalanine derivatives, to show their ability to inhibit
gastrin
-induced acid secretion in the rat in vivo and to compete for the binding of [125I]-(Leu-15)-HG-17 to its cellular receptor on rabbit isolated gastric mucosal cells. N- and C- derivatives of
tryptophan
and phenylalanine were found to inhibit
gastrin
-induced acid secretion and binding of [125I]-(Leu-15)-HG-17 to its mucosal cell receptors. By either criterion, the relative antagonistic potencies of the compounds tested were: tert-butyloxycarbonyl-L-tryphophan-p-nitrophenyl ester approximately equal to tert-butyloxycarbonyl-L-
tryptophan
-carbamoylmethyl ester greater than tert-butyloxycarbonyl-L-tryptophyl-L-methionyl-carbamoylmethyl ester approximately equal to tert-butyloxycarbonyl-L-phenylalanine-carbamoylmethyl ester approximately equal to tert-butyloxycarbonyl-L-tryptophyl-L-methionyl-amide greater than tert-butyloxycarbonyl-L-
tryptophan
greater than tert-butyloxycarbonyl-L-phenylalanine greater than benzyloxycarbonyl-L-
tryptophan
approximately equal to benzotript, with minor differences between the in vivo and the in vitro experiments. These results demonstrate that both the nature of the amino acid residue and the N- and C-substitutions are important in determining antagonist activity and affinity for
gastrin
receptors.
...
PMID:Abilities of some tryptophan and phenylalanine derivatives to inhibit gastric acid secretion. 298 16
The biologically active conformations of a series of four peptides [four cholecystokinin (CCK)-related peptides and enkephalin] in their interactions with gastrointestinal receptors have been deduced using conformational computational analysis. The two peptides that interact exclusively with peripheral-type CCK receptors are the heptapeptide COOH-terminal fragment from CCK (CCK-7) and the analogous sequence from cerulein (CER-7) in which threonine replaces the methionine proximal to the NH2 terminus. The two peptides that interact exclusively with the gastrin receptor in the stomach are the active COOH-terminal fragment of little
gastrin
and the COOH-terminal tetrapeptide sequence common to all of these peptides, CCK-4. We find that preferred conformations for the peripherally active peptides CCK-7 and CER-7 are principally beta-bends, whereas little
gastrin
and CCK-4 are fundamentally helical. In the class of lowest energy structures for both CCK-7 and CER-7, the aromatic rings of the tyrosine and phenylalanine lie close to one another whereas the
tryptophan
indole ring points in the opposite direction. This structure is superimposable on the structures of a set of rigid indolyl benzodiazepine derivatives that interact with complete specificity and high affinity with peripheral CCK receptors further suggesting that the computed beta-bends are the biologically active conformation. The biologically active conformation for CCK-4 and the little
gastrin
hexapeptide has also been deduced. By excluding conformations common to CCK-7 and CCK-4, which do not bond to each other's receptors, and then by selecting conformations in common to CCK-4 and the
gastrin
-related hexapeptide, which do bind to each other's receptors, we deduce that the biologically active conformation at the gastrin receptor is partly helical and one in which the indole of
tryptophan
and the aromatic ring of phenylalanine are close to one another while the methionine and aspartic acid side chains point in the opposite direction. These major differences in preferred structures between the common CCK-7/CER-7 peptides and the common CCK-4/little
gastrin
peptides explain the mutually exclusive activities of these two sets of peptides. We have observed that [Met]enkephalin strongly antagonizes the action of the naturally occurring peripherally active CCK-8 (CCK-7 with an NH2-terminal aspartic acid residue added). The computed lowest energy structures for this opiate peptide closely resemble key features of the computed CCK-7/CER-7 structure, further supporting the proposed structure.
...
PMID:On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system. 303 25
Since previous experiments in dogs suggested L-
tryptophan
to disturb the migrating motor complex (MMC) we set out to study its effects in man. In six healthy volunteers intraduodenal instillation of 50 mmol L-
tryptophan
did not disrupt the interdigestive motility pattern. In comparison to saline L-
tryptophan
caused a brief and local increase of motor activity in the upper small bowel. There was no change in small bowel transit time. The oral intake of 560 kcal liquid formula diet produced a typical digestive pattern for 160-209 min. The increase and the maximum of serum
gastrin
levels did not correspond to the changes of motor activity.
...
PMID:[Effect of L-tryptophan on fasting intestinal motility and intestinal transit time in the human]. 343 51
The effects of the intragastically administered individual L-amino acids, phenylalanine,
tryptophan
, glycine, aspartic acid, and leucine on lower esophageal sphincter (LES) pressure and serum
gastrin
concentration were studied in normal subjects. On separate days and in random, double-blind fashion, 13 adult male subjects received isotonic 0.1 M concentration of amino acids and saline, at pH 5.5 in a volume of 600 ml by rapid intragastric instillation over 5 min. LES pressure and serum
gastrin
concentration were monitored basally and then at frequent intervals for 90 min. Only
tryptophan
had a significant effect on LES pressure when compared with saline, decreasing LES pressure from 20 to 60 min after administration (p less than 0.01). Only phenylalanine and
tryptophan
produced significant stimulation of serum
gastrin
levels with peak increases above basal occurring 30 min after administration (p less than 0.05). It is concluded that: aspartic acid, leucine and glycine produced no significant changes in LES pressure or serum
gastrin
level;
tryptophan
and phenylalanine significantly increased serum
gastrin
concentration;
tryptophan
significantly decreased LES pressure whereas phenylalanine had no effect; the mechanism of inhibition of LES pressure by
tryptophan
is not defined and may be mediated by neural or hormonal pathways possibly involving a duodenal receptor.
...
PMID:Effect of intragastric amino acids on lower esophageal sphincter pressure and serum gastrin in man. 395 32
A case of pancreatic tumor in a six-year-old girl is presented. The tumor had histologic characteristics of acinar cell carcinoma with endocrine component. Grossly, it was encapsulated and attached to the tail of the pancreas, measuring 8 cm in the greatest diameter. Histologically, the tumor was composed of medium-sized tumor cells, with mild pleomorphism showing mainly acinar structures. Many of these tumor cell contained fine granules that were periodic acid-Schiff positive, diastase resistant, and positive with dimethylaminobenzaldehyde nitrite strain for
tryptophan
, and some contained granules that were positive with Grimelius stain and positive with peroxidase-antiperoxidase technic for
gastrin
. Electron microscopy revealed two types of membrane-bound granules in the tumor cells. The larger granules measured 400-700 nm in diameter and appeared to be zymogen granules, while the smaller ones measured 100-200 nm in diameter and appeared to be neuroendocrine granules. Some cells contained both granules. The postoperative course of the patient was excellent, and she was alive and well 13 years after operation. This may be the second reported case of acinar-endocrine cell tumor of the pancreas.
...
PMID:Carcinoma of the pancreas with endocrine component in childhood. A case report. 396 47
1 The intravenous infusion of bombesin elicited in the dog a contraction of the gall bladder with decreased opening pressure of the choledocho-duodenal junction and stimulation of pancreatic secretion.2 The pancreatic juice produced under the influence of bombesin was poor in bicarbonate and rich in protein. Threshold doses of the peptide were of the order of 0.25 mug kg(-1) h(-1) and maximum protein output was obtained with 1 mug kg(-1) h(-1). The pancreatic protein response to bombesin was very similar, in its onset and duration, to that elicited by intraduodenal infusion of L-
tryptophan
. Infusions of bombesin repeated at short intervals produced tachyphylaxis.3 Antrectomy did not affect the stimulant action of bombesin on the pancreas. Atropine however, reduced the pancreatic protein response to bombesin.4 It is suggested that bombesin acts on the gall bladder and the exocrine pancreas through release of cholecystokinin from the duodenal mucosa. No release of secretion could be demonstrated. It is likely that the releasing activity of bombesin is limited, in the field of gastrointestinal peptides, to those belonging to the
gastrin
-cholecystokinin family.
...
PMID:Evidence of cholecystokinin release by bombesin in the dog. 445 17
<< Previous
1
2
3
4
5
Next >>